Stocks
Health Care
aqst
Aquestive Therapeutics
NASDAQ: AQST
-0.11 (-2.68%)
4
USD
At close at Feb 27, 21:42 UTC
Overview
Loading chart...
Key Stats
Market Cap
398.89M
Dividend Yield
0.00%
P/E Ratio
-5.78
EPS
-0.52
Revenue
57.56M
Avg. Volume
2.34M
Recently from Cashu
No Cashu articles
Aquestive Therapeutics currently has no Cashu-related articles
About
What does AQST do?
Aquestive Therapeutics, headquartered in Warren, New Jersey, develops differentiated pharmaceutical products for unmet medical needs, including severe allergic reactions and CNS diseases, using its proprietary PharmFilm technology. The company's portfolio includes Anaphylm and Libervant, with an IPO launched on July 25, 2018.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.